These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 34992845)

  • 1. Fungal infections in lung transplantation.
    Samanta P; Clancy CJ; Nguyen MH
    J Thorac Dis; 2021 Nov; 13(11):6695-6707. PubMed ID: 34992845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis.
    Baker AW; Maziarz EK; Arnold CJ; Johnson MD; Workman AD; Reynolds JM; Perfect JR; Alexander BD
    Clin Infect Dis; 2020 Jan; 70(1):30-39. PubMed ID: 30801642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic antifungal agents used after lung transplantation.
    Marino E; Gallagher JC
    Ann Pharmacother; 2010 Mar; 44(3):546-56. PubMed ID: 20179260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Changing Epidemiology of Invasive Fungal Infections.
    Enoch DA; Yang H; Aliyu SH; Micallef C
    Methods Mol Biol; 2017; 1508():17-65. PubMed ID: 27837497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients at high risk of invasive fungal infections: when and how to treat.
    Rüping MJ; Vehreschild JJ; Cornely OA
    Drugs; 2008; 68(14):1941-62. PubMed ID: 18778118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
    Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year.
    Permpalung N; Liang T; Gopinath S; Bazemore K; Mathew J; Ostrander D; Durand CM; Shoham S; Zhang SX; Marr KA; Avery RK; Shah PD
    J Heart Lung Transplant; 2023 Jul; 42(7):953-963. PubMed ID: 36925381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive fungal infections in critically ill children: epidemiology, risk factors and antifungal drugs.
    Hon KLE; Chan VP; Leung AK; Leung KKY; Hui WF
    Drugs Context; 2024; 13():. PubMed ID: 38915918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal prophylaxis in lung transplantation.
    Avery RK
    Semin Respir Crit Care Med; 2011 Dec; 32(6):717-26. PubMed ID: 22167399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.
    Chong PP; Kennedy CC; Hathcock MA; Kremers WK; Razonable RR
    Clin Transplant; 2015 Apr; 29(4):311-8. PubMed ID: 25604399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.
    Chang A; Musk M; Lavender M; Wrobel J; Yaw MC; Lawrence S; Chirayath S; Boan P
    Transpl Infect Dis; 2019 Jun; 21(3):e13085. PubMed ID: 30925010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and risk factors for mortality of invasive non-Aspergillus mould infections in patients with haematologic diseases: A single-centre 7-year cohort study.
    Lee HJ; Cho SY; Lee DG; Park C; Chun HS; Park YJ
    Mycoses; 2020 Mar; 63(3):257-264. PubMed ID: 31762083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.
    McCoy D; Depestel DD; Carver PL
    Pharmacotherapy; 2009 Nov; 29(11):1306-25. PubMed ID: 19857148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.
    Anesi JA; Baddley JW
    Infect Dis Clin North Am; 2016 Mar; 30(1):277-96. PubMed ID: 26739603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing strategies for the management of invasive fungal infections.
    Rapp RP
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation.
    Linder KA; Kauffman CA; Patel TS; Fitzgerald LJ; Richards BJ; Miceli MH
    Transpl Infect Dis; 2021 Feb; 23(1):e13448. PubMed ID: 33448560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
    Bow EJ; Vanness DJ; Slavin M; Cordonnier C; Cornely OA; Marks DI; Pagliuca A; Solano C; Cragin L; Shaul AJ; Sorensen S; Chambers R; Kantecki M; Weinstein D; Schlamm H
    BMC Infect Dis; 2015 Mar; 15():128. PubMed ID: 25887385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.